2Seventy Bio Inc Financial Flexibility Index
2Seventy Bio Inc financial flexibility index. 2Seventy Bio Inc (TSVT) has a Financial Flexibility Index of -0.04x as of March 2025. Free cash flow of $-10.97 Million (operating CF $-10.97 Million minus capex $0.00) represents 0% of total liabilities ($266.04 Million). See TSVT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of 2Seventy Bio Inc (2019–2024)
Financial flexibility index of 2Seventy Bio Inc from 2019 to 2024. Historical Financial Flexibility Index trend for 2Seventy Bio Inc across 6 annual periods. Check cash flow quality index of 2Seventy Bio Inc to evaluate the quality of earnings relative to operating cash generation.
2Seventy Bio Inc Financial Flexibility Index by Year (2019–2024)
2Seventy Bio Inc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for 2Seventy Bio Inc. For the full cash flow conversion analysis, see 2Seventy Bio Inc (TSVT) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.31x | $-84.29 Million | $-85.00 Million | $268.70 Million | ▲ +36.4% |
| 2023 | -0.49x | $-152.99 Million | $-166.86 Million | $310.13 Million | ▲ +20.3% |
| 2022 | -0.62x | $-214.29 Million | $-237.13 Million | $346.20 Million | ▼ -32.0% |
| 2021 | -0.47x | $-187.46 Million | $-207.03 Million | $399.85 Million | ▼ -145.0% |
| 2020 | -0.19x | $-45.53 Million | $-67.79 Million | $237.99 Million | ▲ +65.0% |
| 2019 | -0.55x | $-148.19 Million | $-207.96 Million | $271.26 Million | — |